Moreover, GO analysis suggested that MB from BD patients were enriched in the AP-1 pathway, IL-18 signaling, MAPK signaling, signaling by interleukins, and response to the interferon-beta pathway (Fig. 3h). The gene discussed is JUN; the disease is Behcet disease.